Close X
Tuesday, November 19, 2024
ADVT 
National

Aritzia signs deal to buy Reigning Champ

Darpan News Desk The Canadian Press, 15 Jun, 2021 09:37 AM
  • Aritzia signs deal to buy Reigning Champ

Clothing designer and retailer Aritzia Inc. says it has signed an agreement to buy a Reigning Champ, a designer and manufacturer of premium athletic wear.

Under the agreement, Aritzia will acquire a 75 per cent stake in the company based on an enterprise value of approximately $63 million.

The remaining 25 per cent interest held by Reigning Champ's management shareholders will be converted into Aritzia shares in up to three instalments from 2024 to 2026.

Aritzia chief executive Brian Hill says the deal accelerates the company's expansion into men's clothing.

Reigning Champ's senior leadership team will continue operating the business in partnership with Aritzia through a transition period of approximately five years.

The deal is expected to be completed later this month, subject to customary closing conditions and approvals.

 

MORE National ARTICLES

PM holds firm on premiers' health-care demands

PM holds firm on premiers' health-care demands
Speaking at a midday press conference, Trudeau said that short-term outlook can't yet give way to longer-term concerns about the effect COVID-19 is having on the Canada's provincially run health-care systems.

PM holds firm on premiers' health-care demands

Two injured after B.C. helicopter crash

Two injured after B.C. helicopter crash
B.C. Emergency Health Services says in a statement that they received a call at about 10 a.m. Friday morning for reports of a downed helicopter on the island off the coast of West Vancouver.

Two injured after B.C. helicopter crash

Dentists, teachers want AstraZeneca shot in B.C.

Dentists, teachers want AstraZeneca shot in B.C.
BC Teachers' Federation president Teri Mooring says her members should be included in the plan expected to be released by the B.C. Immunization Committee by March 18.

Dentists, teachers want AstraZeneca shot in B.C.

What we know about J&J's single COVID-19 shot

What we know about J&J's single COVID-19 shot
The U.S.-based Food and Drug Administration (FDA) approved the Johnson & Johnson vaccine for emergency use on Feb. 27.

What we know about J&J's single COVID-19 shot

Van attack trial offers glimpse into virtual court

Van attack trial offers glimpse into virtual court
Ontario's courts issued guidance to those in the justice system when the health crisis began last year, as did several legal organizations.

Van attack trial offers glimpse into virtual court

Health Canada approves Johnson & Johnson vaccine

Health Canada approves Johnson & Johnson vaccine
Health Canada announced the approval of the COVID-19 vaccine from Johnson & Johnson, saying regulators have evidence showing the vaccine is both safe and effective against the novel coronavirus that causes the disease.

Health Canada approves Johnson & Johnson vaccine